Ligand · QMN
QMN · ethyl (9S)-9-[3-(1H-benzimidazol-2-yloxy)phenyl]-8-oxo-4,5,6,7,8,9-hexahydro-2H-pyrrolo[3,4-b]quinoline-3-carboxylate
QMN, ethyl (9S)-9-[3-(1H-benzimidazol-2-yloxy)phenyl]-8-oxo-4,5,6,7,8,9-hexahydro-2H-pyrrolo[3,4-b]quinoline-3-carboxylate (C27 H24 N4 O4, 468.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding…
- Component
- QMN
- Formula
- C27 H24 N4 O4
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
QMN in 2 structures; the first of them:
- 4UZD · SAR156497 an exquisitely selective inhibitor of Aurora kinases · QMN A1389 · binds LEU139, GLY140, LYS141, GLY142, VAL147, ALA160, LYS162, LEU178 and 14 more
- 4UZD · SAR156497 an exquisitely selective inhibitor of aurora kinases · QMN A1389 · binds LEU139, GLY140, LYS141, GLY142, VAL147, ALA160, LYS162, LEU178 and 14 more
Residues it binds most
LEU 4, GLY 4, ALA 4, GLU 4, LYS 4, VAL 4, GLN 4, PHE 4, TYR 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.